CD274 and prostate carcinoma: Consistently, these analyses demonstrated that SFN effectively blocked PD-L1 induction in multiple human cancer cell lines, including A498 kidney cancer cells (Fig. 2B–D), H1299 lung cancer cells (Figs. S2A–C), and DU145 prostate cancer cells (Figs. S2D–F).